Product Information
METHYLPHENIDATE 20 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.2095 per EA under NDC 16729048001. Its NADAC has been published 284 times since Jan 20, 2021.
Strength
20 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729048001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213936On Market Since
12/17/2020
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE 20 MG TABLET has been published 284 times since Jan 20, 2021, and over the history we have for it it has declined 16.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2095 per EA |
|---|---|
| All-time high | $0.2681 (Jun 16, 2021) |
| All-time low | $0.1079 (Apr 17, 2024) |
| 52-week high | $0.2332 |
| 52-week low | $0.1962 |
| Median price | $0.2024 |
| Average price | $0.2026 |
| Largest weekly change | +108.2% (Aug 21, 2024) |
| Weeks tracked | 284 |
| Tracking since | Jan 20, 2021 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE 20 MG TABLET, manufactured by Accord Healthcare Inc., is $0.2095 per EA (NDC 16729048001), effective Jun 24, 2026.
How has the price of METHYLPHENIDATE 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE 20 MG TABLET has declined 16.8%. It has been tracked across 284 weekly CMS publications since Jan 20, 2021.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE 20 MG TABLET?
Since Jan 20, 2021, the NADAC for METHYLPHENIDATE 20 MG TABLET has ranged from a low of $0.1079 (Apr 17, 2024) to a high of $0.2681 (Jun 16, 2021), with a median of $0.2024 per EA.
Are there cheaper alternatives to METHYLPHENIDATE 20 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as METHYLPHENIDATE 20 MG TABLET, but none are currently priced below it.
Who manufactures METHYLPHENIDATE 20 MG TABLET?
METHYLPHENIDATE 20 MG TABLET (NDC 16729048001) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification